Skip to main content

Closed

EDSA: Edesa Biotech, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-108.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio4.76×

Edesa Biotech, Inc.

EDSANASDAQ Capital Market·USD·Closed

Edesa Biotech, Inc.

EDSANASDAQ·USD·Closed

$5.11

−2.67%

$5.11

−$0.14 (2.67%)

52W Range

22thpctl

Volume

0.26×avg

Mkt Cap

49.23MUSD

P/E

-3.8TTM

Div Yield

–ann

52W Range

22thpctl

Volume

0.26×avg

Market Cap

49.23MUSD

P/E Ratio

-3.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings